182 related articles for article (PubMed ID: 9758341)
61. [Hematopoietic recovery as a function of the number of autografted CD34+ cells: a retrospective study of 66 patients with malignant hematologic diseases].
Boulassel MR; De Bruyère M; Nguyen BT; Straetmans N; Ferrant A
Acta Clin Belg; 1999 Aug; 54(4):191-6. PubMed ID: 10544508
[TBL] [Abstract][Full Text] [Related]
62. Haematopoietic reconstitution after autologous transplantation of CD34(+)-selected versus non-selected peripheral blood progenitor cells.
Wiesneth M; Schreiner T; Sandherr M; Maccari B; Erne E; Bischof C; Frickhofen N; von Schilling C; Kubanek B
Beitr Infusionsther Transfusionsmed; 1997; 34():133-8. PubMed ID: 9356664
[TBL] [Abstract][Full Text] [Related]
63. Highly fluorescent reticulocytes after CD34+ peripheral blood progenitor cell transplantation.
Sica S; Salutari P; Laurenti L; Ortu La Barbera E; Zini G; d'Onofrio G; Serafini R; Leone G
Bone Marrow Transplant; 1998 Feb; 21(4):361-4. PubMed ID: 9509969
[TBL] [Abstract][Full Text] [Related]
64. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
[TBL] [Abstract][Full Text] [Related]
65. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients.
Moreb JS; Kubilis PS; Mullins DL; Myers L; Youngblood M; Hutcheson C
Bone Marrow Transplant; 1997 Jan; 19(2):101-6. PubMed ID: 9116605
[TBL] [Abstract][Full Text] [Related]
66. The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.
Hicks C; Trickett A; Kwan YL; Ramanathan S
Ann Hematol; 2012 Nov; 91(11):1795-801. PubMed ID: 22836946
[TBL] [Abstract][Full Text] [Related]
67. [Autotransplant of CD34+ stem cells from peripheral blood separated using an immunomagnetic method in cancer of the breast].
Correa MA; González A; Garzón S; Rubio V; Hermosín L; Campos R; Jean-Paul E; Guzmán JL; Romero R; Gutiérrez R; Couto C; León A
Sangre (Barc); 1997 Apr; 42 Suppl 1():57-60. PubMed ID: 9381306
[No Abstract] [Full Text] [Related]
68. Peripheral blood CD34+ cell count reliably predicts autograft yield.
Chapple P; Prince HM; Quinn M; Bertoncello I; Juneja S; Wolf M; Januszewicz H; Brettell M; Gardyn J; Seymour C; Venter D
Bone Marrow Transplant; 1998 Jul; 22(2):125-30. PubMed ID: 9707018
[TBL] [Abstract][Full Text] [Related]
69. A randomized study of multi-day infusion of autologous peripheral blood progenitor cells.
Abdel-Razeq H; Pohlman B; Andresen S; Kalaycio M; Overmoyer B; Wise K; Dannley R; DeMars D; Goormastic M; Bolwell B
Bone Marrow Transplant; 1998 Feb; 21(3):221-3. PubMed ID: 9489643
[TBL] [Abstract][Full Text] [Related]
70. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation.
Ravoet C; Feremans W; Husson B; Majois F; Kentos A; Lambermont M; Wallef G; Capel P; Beauduin M; Delannoy A
Bone Marrow Transplant; 1996 Nov; 18(5):943-7. PubMed ID: 8932849
[TBL] [Abstract][Full Text] [Related]
71. Peripheral blood progenitor cell mobilization: a clinical review.
Kennedy MJ
Pharmacotherapy; 1998; 18(1 Pt 2):3S-8S. PubMed ID: 9473173
[TBL] [Abstract][Full Text] [Related]
72. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies.
Ketterer N; Salles G; Moullet I; Dumontet C; ElJaafari-Corbin A; Tremisi P; Thieblemont C; Durand B; Neidhardt-Berard EM; Samaha H; Rigal D; Coiffier B
Br J Haematol; 1998 Oct; 103(1):235-42. PubMed ID: 9792315
[TBL] [Abstract][Full Text] [Related]
73. Erythroid burst-forming units (BFU-E) predict hematopoietic recovery after peripheral blood progenitor cell transplantation in patients with advanced breast cancer.
Cooper BW; Mackay W; Gerson SL; Lazarus HM
Bone Marrow Transplant; 1997 Jun; 19(11):1089-94. PubMed ID: 9193751
[TBL] [Abstract][Full Text] [Related]
74. High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.
Lefrère F; Delarue R; Somme D; Levy V; Damaj G; Tu A; Porcher R; Audat F; Boulat C; Cavazzana-Calvo M; Buzyn A; Belanger C; Maillard N; Hermine O; Varet B
Transfusion; 2002 Apr; 42(4):443-50. PubMed ID: 12076291
[TBL] [Abstract][Full Text] [Related]
75. High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation.
Ketterer N; Salles G; Raba M; Espinouse D; Sonet A; Tremisi P; Dumontet C; Moullet I; Eljaafari-Corbin A; Neidhardt-Berard EM; Bouafia F; Coiffier B
Blood; 1998 May; 91(9):3148-55. PubMed ID: 9558369
[TBL] [Abstract][Full Text] [Related]
76. Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: comparison of bone marrow and peripheral blood progenitor cells.
Brice P; Marolleau JP; Pautier P; Makke J; Cazals D; Dombret H; D'Agay MF; Benbunan M; Gisselbrecht C
Leuk Lymphoma; 1996 Aug; 22(5-6):449-56. PubMed ID: 8882958
[TBL] [Abstract][Full Text] [Related]
77. Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSD.
Trivedi M; Martinez S; Corringham S; Medley K; Ball ED
J Oncol Pharm Pract; 2011 Jun; 17(2):85-90. PubMed ID: 20015929
[TBL] [Abstract][Full Text] [Related]
78. CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.
Zimmerman TM; Lee WJ; Bender JG; Mick R; Williams SF
Prog Clin Biol Res; 1994; 389():303-8. PubMed ID: 7535435
[No Abstract] [Full Text] [Related]
79. Analysis of engraftment kinetics in pediatric patients undergoing autologous PBPC transplantation.
Díaz MA; Villa M; Madero L; Benito A; Alegre A; Fernandez-Rañada JM
J Hematother; 1998 Aug; 7(4):367-73. PubMed ID: 9735868
[TBL] [Abstract][Full Text] [Related]
80. Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.
Warkentin PI; Jackson JD; Letheby B; Kessinger A
Prog Clin Biol Res; 1994; 389():643-7. PubMed ID: 7700931
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
